Cargando…
GLA-AF, an Emulsion-Free Vaccine Adjuvant for Pandemic Influenza
The ongoing threat from Influenza necessitates the development of new vaccine and adjuvant technologies that can maximize vaccine immunogenicity, shorten production cycles, and increase global vaccine supply. Currently, the most successful adjuvants for Influenza vaccines are squalene-based oil-in-w...
Autores principales: | Clegg, Christopher H., Roque, Richard, Perrone, Lucy A., Rininger, Joseph A., Bowen, Richard, Reed, Steven G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3925208/ https://www.ncbi.nlm.nih.gov/pubmed/24551202 http://dx.doi.org/10.1371/journal.pone.0088979 |
Ejemplares similares
-
The adjuvant GLA-AF enhances human intradermal vaccine
responses
por: Carter, Darrick, et al.
Publicado: (2018) -
Adjuvanted pandemic influenza vaccine: variation of emulsion components affects stability, antigen structure, and vaccine efficacy
por: Fox, Christopher B., et al.
Publicado: (2012) -
Preparedness against pandemic influenza: Production of an oil-in-water emulsion adjuvant in Brazil
por: Akamatsu, Milena Apetito, et al.
Publicado: (2020) -
The TLR4 Agonist Vaccine Adjuvant, GLA-SE, Requires Canonical and Atypical Mechanisms of Action for T(H)1 Induction
por: Cauwelaert, Natasha Dubois, et al.
Publicado: (2016) -
A Synthetic Adjuvant to Enhance and Expand Immune Responses to Influenza Vaccines
por: Coler, Rhea N., et al.
Publicado: (2010)